JO2359B1 - Benzathene derivatives as agents for modulation of GABA A receptor - Google Patents

Benzathene derivatives as agents for modulation of GABA A receptor

Info

Publication number
JO2359B1
JO2359B1 JO2001183A JOP20010183A JO2359B1 JO 2359 B1 JO2359 B1 JO 2359B1 JO 2001183 A JO2001183 A JO 2001183A JO P20010183 A JOP20010183 A JO P20010183A JO 2359 B1 JO2359 B1 JO 2359B1
Authority
JO
Jordan
Prior art keywords
gaba
receptor modulators
benzodiazepine derivatives
receptor
compounds
Prior art date
Application number
JO2001183A
Other languages
Arabic (ar)
English (en)
Inventor
ماسيادري رافيللو
ويليام ثوماس اندرو
ويتشمان جيورجن
Original Assignee
اف . هوفمان- لاروش أيه جي
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by اف . هوفمان- لاروش أيه جي filed Critical اف . هوفمان- لاروش أيه جي
Application granted granted Critical
Publication of JO2359B1 publication Critical patent/JO2359B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
JO2001183A 2000-11-16 2001-11-12 Benzathene derivatives as agents for modulation of GABA A receptor JO2359B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16

Publications (1)

Publication Number Publication Date
JO2359B1 true JO2359B1 (en) 2006-12-12

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
JO2001183A JO2359B1 (en) 2000-11-16 2001-11-12 Benzathene derivatives as agents for modulation of GABA A receptor

Country Status (40)

Country Link
US (1) US6743789B2 (enExample)
EP (1) EP1337535B1 (enExample)
JP (1) JP4088151B2 (enExample)
KR (1) KR100504300B1 (enExample)
CN (1) CN1191255C (enExample)
AR (1) AR031345A1 (enExample)
AT (1) ATE268776T1 (enExample)
AU (2) AU1700702A (enExample)
BG (1) BG107817A (enExample)
BR (1) BR0115393A (enExample)
CA (1) CA2427576C (enExample)
CZ (1) CZ295256B6 (enExample)
DE (1) DE60103776T2 (enExample)
DK (1) DK1337535T3 (enExample)
EC (1) ECSP034607A (enExample)
ES (1) ES2220831T3 (enExample)
GC (1) GC0000375A (enExample)
GT (1) GT200100230A (enExample)
HR (1) HRP20030360A2 (enExample)
HU (1) HUP0303281A3 (enExample)
IL (1) IL155813A0 (enExample)
JO (1) JO2359B1 (enExample)
MA (1) MA26962A1 (enExample)
MX (1) MXPA03004251A (enExample)
MY (1) MY141675A (enExample)
NO (1) NO324706B1 (enExample)
NZ (1) NZ525413A (enExample)
PA (1) PA8532401A1 (enExample)
PE (1) PE20020583A1 (enExample)
PL (1) PL362925A1 (enExample)
PT (1) PT1337535E (enExample)
RU (1) RU2278865C2 (enExample)
SI (1) SI1337535T1 (enExample)
SK (1) SK7232003A3 (enExample)
TR (1) TR200402073T4 (enExample)
TW (1) TWI239333B (enExample)
UY (1) UY27026A1 (enExample)
WO (1) WO2002040487A2 (enExample)
YU (1) YU35603A (enExample)
ZA (1) ZA200303435B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
EP1634879A4 (en) * 2003-06-19 2007-09-05 Daiichi Seiyaku Co METHOD FOR THE SELECTIVE INTRODUCTION OF AN AMINO SUBSTITUENT
JP5646126B2 (ja) 2003-12-11 2014-12-24 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． 鎮静剤と神経伝達物質調節剤の併用、および睡眠の質の向上方法および鬱の治療方法
WO2006020959A2 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
CA2581918A1 (en) * 2004-10-12 2006-04-20 Henner Knust Imidazo(1,5-a)triazolo(1,5-d) benzodiazepine deratives for the treatment of cognitive disorders
RU2007114763A (ru) * 2004-10-20 2008-11-27 Ф.Хоффманн-Ля Рош Аг (Ch) Галогенозамещенные производные бензодиазепинов
ES2399439T3 (es) * 2004-10-20 2013-04-01 F. Hoffmann-La Roche Ag Derivados de imidazo-benzodiazepina
BRPI0515800A (pt) * 2004-12-14 2008-08-05 Hoffmann La Roche imidazo-benzodiazepinas tetracìclicas como moduladores de receptores de gaba
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
EP1924712B1 (en) * 2005-08-03 2018-10-03 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
EP1937688B1 (en) 2005-10-11 2010-08-11 F. Hoffmann-La Roche AG Imidazo benzodiazepine derivatives
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US9156836B2 (en) * 2008-05-16 2015-10-13 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate HSP90 activity
KR101385433B1 (ko) * 2008-11-18 2014-04-14 에프. 호프만-라 로슈 아게 다이하이드로테트라아자벤조아줄렌의 알킬사이클로헥실에터
DK2370441T3 (da) * 2008-11-28 2013-10-21 Hoffmann La Roche Arylcyclohexylethere af dihydrotetraazabenzoazulener til anvendelse som vasopressin v1a-receptorantagonister
CU20090172A7 (es) 2009-10-09 2011-10-05 Ct De Investigación Y Desarrollo De Medicamentos Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
DK3034079T3 (en) 2010-11-15 2018-02-05 Agenebio Inc PYRIDAZINE DERIVATIVES, COMPOSITIONS AND PROCEDURES FOR TREATING COGNITIVE WEAKNESS
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
WO2014047413A1 (en) * 2012-09-21 2014-03-27 Uwm Research Foundation, Inc. Novel gabaa agonists and methods of using to control airway hyperresponsiveness and inflammation in asthma
CA3123897C (en) * 2013-12-20 2024-02-06 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN108026107B (zh) 2015-06-19 2021-07-30 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio Inc derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
WO2019246300A1 (en) 2018-06-19 2019-12-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
US20240132513A1 (en) 2022-08-19 2024-04-25 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (enExample) * 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
HRP20030360A2 (en) 2005-04-30
GC0000375A (en) 2007-03-31
PA8532401A1 (es) 2002-08-26
ATE268776T1 (de) 2004-06-15
KR20030045192A (ko) 2003-06-09
BR0115393A (pt) 2004-07-06
AU1700702A (en) 2002-05-27
HUP0303281A2 (hu) 2004-01-28
ECSP034607A (es) 2003-06-25
AR031345A1 (es) 2003-09-17
PT1337535E (pt) 2004-09-30
HK1062442A1 (en) 2004-11-05
WO2002040487A2 (en) 2002-05-23
IL155813A0 (en) 2003-12-23
SK7232003A3 (en) 2004-03-02
MA26962A1 (fr) 2004-12-20
SI1337535T1 (en) 2004-10-31
CZ20031597A3 (cs) 2003-11-12
ES2220831T3 (es) 2004-12-16
DE60103776D1 (de) 2004-07-15
CN1474820A (zh) 2004-02-11
JP4088151B2 (ja) 2008-05-21
CN1191255C (zh) 2005-03-02
RU2278865C2 (ru) 2006-06-27
HUP0303281A3 (en) 2005-05-30
JP2004517070A (ja) 2004-06-10
ZA200303435B (en) 2004-08-05
CZ295256B6 (cs) 2005-06-15
UY27026A1 (es) 2002-06-20
CA2427576A1 (en) 2002-05-23
MXPA03004251A (es) 2003-09-22
NO20032208L (no) 2003-05-15
CA2427576C (en) 2007-11-06
US20020103371A1 (en) 2002-08-01
DK1337535T3 (da) 2004-10-25
RU2003116895A (ru) 2005-02-20
PL362925A1 (en) 2004-11-02
NO324706B1 (no) 2007-12-03
EP1337535B1 (en) 2004-06-09
TWI239333B (en) 2005-09-11
AU2002217007B2 (en) 2006-11-30
PE20020583A1 (es) 2002-07-06
BG107817A (bg) 2004-07-30
WO2002040487A3 (en) 2002-09-26
DE60103776T2 (de) 2005-07-14
NO20032208D0 (no) 2003-05-15
MY141675A (en) 2010-06-15
EP1337535A2 (en) 2003-08-27
NZ525413A (en) 2005-02-25
TR200402073T4 (tr) 2004-10-21
US6743789B2 (en) 2004-06-01
KR100504300B1 (ko) 2005-07-28
GT200100230A (es) 2002-07-04
YU35603A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
JO2359B1 (en) Benzathene derivatives as agents for modulation of GABA A receptor
AU3652102A (en) Compounds and their uses
BG103870A (en) Substituted benzopyran derivatives for the treatment of inflammations
AU5242000A (en) Nematicidal trifluorobutenes
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
BG102976A (en) Method for the preparation of drospyrenon (6 beta,7 beta: 15 beta,16 beta - dimethylene-3-oxo-17 alpha -pregn-4-ene-21,17-carbolacton, drsp)as well as 7 alpha-(3-hydroxy-1-propyl)-(6 beta,7 beta: 15 beta,16 beta -dirmethylene-5 beta-androstan-3 beta,5,17 beta -triol (zk 92836) and (6 beta,7 beta: 15 beta,16 beta - dimethylene-5 beta-hydroxy-3-oxo-17 alpha -androstan-21, 17-carbolacton (90965) as intermediate compounds of the method
AU7743001A (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
MY134559A (en) Lactam compound to inhibit beta-amyloid peptide release or synthesis
EP0911321A3 (en) Compounds for the treatment of osteoporosis
IL157478A0 (en) Method for the synthesis of 2', 3'-didehydronucleosides
MXPA02009773A (es) Derivados de indolin-2-ona y su uso como ligandos de receptores de ocitocina.
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
WO2003057145A3 (en) SUBSTITUTED 4,9-DIHYDROCYCLOPENTA[imn]PHENANTHRIDINE-5-ONES DERIVATIVES THEREOF AND THEIR USES
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
WO1998058911A3 (en) Prostaglandin agonists
BG105197A (en) Polymorph form of a medicament
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
MY133390A (en) Azabicyclic 5ht1 receptor ligands
UA66866C2 (uk) Синтез морфолінових похідних
BG103649A (en) Method for the preparation of eprosartan
AU7525398A (en) Inhibitors for urokinase receptor
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
BG103650A (en) Method for the preparation of eprosartan
BG102229A (en) Endothelium receptor antagonists